UNSPSC 41202066: Treponema pallidumtreponemal test reagents

In this classification, Treponema pallidum treponemal test reagents are devices used in test to identify specific Treponema pallidum treponemal test reagents antibodies in serum. US FDA regulates Treponema pallidum treponemal test reagents under 21 CFR 866.3830 and under FDA product code GMS.

UNSPSC 41202066 Treponema pallidumtreponemal test reagents is a Commodity code covering rapid diagnostic test kits and reagents for syphilis and related treponemal testing that state and local health departments and correctional agencies procure for sexually transmitted infection surveillance, clinical screening, and public health disease control. Recent solicitations show state and local buyers purchasing HIV and syphilis rapid test kits, NG/CT (gonorrhea and chlamydia) nucleic acid amplification test reagents compatible with specific analyzer platforms (Hologic Panther NAAT, Abbott ARCHITECT), and laboratory reagent suites bundled with calibrators, controls, and consumables for high-volume testing operations. The issuing-body mix spans state health departments (Illinois Department of Public Health), county health authorities (Collin County Health Care Services), county criminal justice agencies (Collin County Community Supervision and Corrections, Gwinnett County), city public health programs (Austin Public Health), and state correctional agencies (Texas Department of Criminal Justice). The Illinois Department of Public Health appears as a repeat buyer, having posted emergency sole-source procurements for Abbott HIV and Syphilis reagents in May 2026 and a change-order notice in September 2026 to increase NG/CT testing volume under an existing Hologic rental-reagent agreement.

Recent activity concentrates in Texas, Illinois, and Georgia. The Illinois Department of Public Health issued an emergency procurement for Abbott HIV/Syphilis reagents with a due date of August 18, 2026 and a subsequent change-order notice (IFB, due October 13, 2026) to increase annual NG/CT testing from 15,000 to 25,000 tests and collection kits from 15,000 to 30,000 units, raising the five-year contract cost from $525,000 to $900,000. The City of Austin posted two separate solicitations (IFB 9100 AAM1023 and IFB 9100 AAM1023 REBID) for Abbott Determine HIV 1/2 Ag/Ab Combo Test kits and controls with response dates in July and September 2026, estimating annual demand at 375 test kits and 79 control kits. Collin County, Texas issued an RFP for offender specimen collection and drug testing services (RFP 2026-327, due July 23, 2026) encompassing immunoassay screening and LC/MS/MS or GC/MS confirmation with approximately 25,031 annual tests and an estimated contract value of $600,000. Gwinnett County, Georgia posted an RFQ for drug testing supplies compatible with a drugs of abuse analyzer (due October 14, 2026) with limited scope detail in available documentation.